LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.01 | 27.76 | 67 | 2662 | 0.0252 | 0.1432 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.01 | 27.76 | 1139 | 2662 | 0.4277 | 0.7580 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.71 | 27.76 | 24 | 2877 | 0.0083 | -0.0215 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.71 | 27.76 | 975 | 2877 | 0.3388 | 0.7015 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.71 | 27.76 | 75 | 2877 | 0.0261 | 0.1600 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.71 | 27.76 | 1170 | 2877 | 0.4066 | 0.7485 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.41 | 27.76 | 31 | 3105 | 0.0100 | 0.0164 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.41 | 27.76 | 985 | 3105 | 0.3172 | 0.6895 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.41 | 27.76 | 82 | 3105 | 0.0264 | 0.1725 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.41 | 27.76 | 1171 | 3105 | 0.3771 | 0.7330 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.11 | 27.76 | 22 | 3331 | 0.0066 | -0.0331 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.11 | 27.76 | 981 | 3331 | 0.2945 | 0.6756 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.11 | 27.76 | 78 | 3331 | 0.0234 | 0.1614 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.11 | 27.76 | 1181 | 3331 | 0.3545 | 0.7212 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.81 | 27.76 | 24 | 3596 | 0.0067 | -0.0205 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.81 | 27.76 | 992 | 3596 | 0.2758 | 0.6647 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.81 | 27.76 | 80 | 3596 | 0.0222 | 0.1628 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.81 | 27.76 | 1187 | 3596 | 0.3301 | 0.7078 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.52 | 27.76 | 27 | 3884 | 0.0070 | -0.0039 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.52 | 27.76 | 989 | 3884 | 0.2546 | 0.6508 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.52 | 27.76 | 102 | 3884 | 0.0263 | 0.2003 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.52 | 27.76 | 1215 | 3884 | 0.3128 | 0.6991 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.22 | 27.76 | 31 | 4125 | 0.0075 | 0.0154 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.22 | 27.76 | 1019 | 4125 | 0.2470 | 0.6477 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.22 | 27.76 | 111 | 4125 | 0.0269 | 0.2118 | MN20160318_Q01 | N12 |